Amar A. Sethi
Chief Scientific OfficerDr. Amar A. Sethi, M.D., Ph.D. serves as Chief Scientific Officer at VivoSim Labs, Inc. since November 24, 2025. He joined the VivoSim Labs, Inc. on November 24, 2025. He was the President at Bio-Newco, Inc. (alternatively Emerald Star Holdings, LLC) since January 27, 2016 until April 2019 and its Chief Medical Officer since December 2018 until April 2019. Dr. Sethi joined Pacific Biomarkers in 2009 was the Chief Scientific Officer since January 1, 2012 until December 2018. He served as Vice President of Research and Development at NorWesTech, Inc. He was focusing on innovative biomarkers to elucidate the role of HDL in cardiovascular disease. He served as the Vice President of Science & Technology at NorWesTech, Inc. since July 15, 2009. His research has focused on genetic variations related to cardiovascular disease and most recently, on composition and function of HDL in patients with ischemic heart disease and on apo-AI mimetic peptides in animal models of atherosclerosis. He holds numerous awards and honors in both Denmark and the US, has presented extensively at international scientific meetings and has published widely in international, peer-reviewed journals. In 2008, he was a Postdoctoral Fellow at the National Heart, Lung and Blood Institute, Pulmonary and Vascular Medicine Branch, National Institutes of Health (NIH) and in 2008 he commenced a clinical chemistry fellowship in the Department of Laboratory Medicine, NIH overseeing the Immunology section while continuing his research. He was honored by R&D Directions as one of the Most Notable People in R&D. R&D Directions' selection of the Most Notable People in R&D pays tribute to those who have led and made the significant breakthroughs in the discovery and development of drugs that indelibly change the ways in which particular diseases are treated. He trained as a Physician at the University of Copenhagen in Denmark in 1996. In 2003, he was awarded a PhD in Genetic Epidemiology from University of Copenhagen, School of Medicine, Denmark and in 2005 he became board certified in Chemical Pathology by the National Board of Health, Denmark. He holds M.D. in 1996 from the University of Copenhagen, School of Medicine, Denmark.
Positions
- Company NameVivoSim Labs, Inc.Stock CodeVIVSPositionChief Scientific OfficerColleagues
- KEKeith E. MurphyExecutive Chairman & Corporate Secretary
- NSNorman StaskeyPresident, CFO & Principal Financial Officer
- TLTony LialinChief Commercial Officer
- DJDouglas Jay CohenLead Independent Director
- DGDavid GobelIndependent Director
- ATAlison Tjosvold MilhousIndependent Director
- AKAdam K. SternIndependent Director
